NMT Logo
    • About NMT Medical
      • Who we are
      • Our History
      • Our Executive Team
      • Scientific Advisory Board
      • Careers
        • Career Opportunities
        • Application for Employment
      • Directions
    • Structural Heart Repair
      • Patent Foramen Ovale
      • Atrial Septal Defect
      • Ventricular Septal Defect
      • FDA Disclaimer
    • NMT Technology
      • Technology Overview
      • Clinical History
      • BioSTAR®
        • Clinical Trials
        • Technology-Approach
      • STARFlex®
        • Clinical Trials
        • Technology Approach
      • CardioSEAL®
        • Technology Approach
    • Patient Education
      • Signs of Stroke
      • 10 Questions to ask your Doctor
      • Patient Guides
        • Brazilian Portuguese
        • Danish
        • Dutch
        • English
        • Finnish
        • French
        • German
        • Italian
        • Norwegian
        • Portuguese
        • Spanish
        • Swedish
      • Patients Videos
    • Medical Professional
      • MRI Safety
      • Presentations
      • Medical Professional Videos
      • Clinical Trials
      • Conference Calendar
      • Instructions for Use
      • Newsletter
        • 2009 clinical trial update
        • Issue 1 2009
        • Issue 2 2009
        • Issue 3 2009
        • Issue 4 2009
        • Issue 1 2010
      • Publications
    • Investors
      • Corporate Profile
      • Stock Information
        • Historic Prices
      • Press Releases
      • Event Calendar
      • Archived Webcasts
      • Presentations
      • Corporate Governance
        • Officers & Directors
        • Governance Documents
        • Committee Composition
      • Annual Reports
      • Annual Meeting and Proxy
      • Clinical Studies
      • Fact Sheet
      • SEC Filings
      • Email Notification
      • Information Request
      • FAQs
    • Contact Us
      • Contact Information
      • Contact Us Form

Technology

  • NMT Technology
    • Technology Overview
    • Clinical History
    • BioSTAR®
      • Clinical Trials
      • Technology-Approach
    • STARFlex®
      • Clinical Trials
      • Technology Approach
    • CardioSEAL®
      • Technology Approach

Publications

What is a PFO?
What is an ASD?
What is a VSD? 

BioSTAR® Technology/Approach

BioSTAR® bioabsorbable septal repair implant is constructed from a low profile, MP35N framework to which Intestinal Collagen Layer (ICL) is securely attached. BioSTAR® is comprised of two umbrella shaped discs one for each side of the septum. Both the framework and ICL are made from the most biocompatible/bioabsorbable materials known for this application. The framework has been selected for its excellent biocompatibility, compliance and profile. ICL has been selected for its ability to remodel, its bioabsorbability, purity4-7 and its ability to promote site-specific tissue regeneration as opposed to scar tissue formation1-4 providing  flexibility and strength.4,5,7 

The BioSTAR® implant can be collapsed into a very small tube (catheter) for insertion into the heart. Once inserted through the catheter, the BioSTAR® implant is opened, with one umbrella positioned on each side of the defect. The spring coil design gives BioSTAR® unique features:

  • It holds the BioSTAR® implant securely in place at the site of the defect.
  • The unique design of the frame allows the device to conform to variations in the anatomy of the septum, keeping a low profile without obstructing the normal flow of blood through the atria.
  • A self centering system to help with placement and a more complete closure.

BioSTAR® bioabsorbable septal repair implant is designed to make the implant more effective in sealing the defect and speeding up the healing process.  90-95% of the implant will be replaced by healthy tissue within two years.

It is implanted in the identical way as prior generations, but is generations ahead in the clinical benefits it offers.

Procedures using NMT’s BioSTAR® bioabsorbable septal repair implants are less invasive and less costly than open-heart surgery. The procedure is performed by an interventional cardiologist in the catheterization laboratory and typically lasts less than one hour. The patient is usually allowed to return home the same day or the following morning. Since surgery is not involved, the patient is able to get back to an active lifestyle in just a short time following the procedure.

The BioSTAR® bioabsorbable septal repair implant may offer an alternative to the traditional treatment of continuous lifelong drug therapy and the lifestyle restrictions that this may impose.

 Please contact NMT Medical, Inc. for questions regarding specific geographic locations where these products are commercially available.

[1]Transpl Immunol 2004;12:367–77

[2] J Biomed Mater Res 1995;29:977–85

[3]Surg Innov 2005;12:227–31

[4]Nat Biotechnol 1999;17:1083–6

[5]J Biomed Mater Res 2000; 51:442-452

[6]Biotechnol Bioeng 1996;49:675– 82

[7]J Biomed Mater Res 2001;56:101–8

Quick Links

Conference Calendar
Press Releases
Webcasts 

family

"When you have children depend on you, migraine has a massive impact."

Liz Norwood

Learn More

 

Home | About NMT Medical | Structural Heart Repair | NMT Technology | Patient Education | Medical Professionals
Investors | Contact Us | Privacy Policy | Glossary | Login

All content © 2009 NMT Medical, Inc.
NMT Medical, Inc., 27 Wormwood Street, Boston, MA 02210 | 617.737.0930 
Web Design and Web Development by Wakefly                                                                             ML-0061-03